Original articleIncreased serum levels of interleukin-1β in the systemic circulation of patients with essential hypertension: Additional risk factor for atherogenesis in hypertensive patients?☆
References (55)
- et al.
Immunopathogenic mechanisms in hypertension
Am J Hypertens
(1995) - et al.
Increased serum IgG levels in essential hypertension
Immunol Lett
(1984) - et al.
The cytokine network
Immunol Today
(1989) - et al.
Interlukin-1: the first interleukin
Immunol Today
(1990) - et al.
Interleukin-1: biology, pathophysiology and clinical prospects
Am J Med
(1990) - et al.
Signal transdution events leading to T-cell lymphokine gene expression
Immunol Today
(1993) - et al.
Plasma levels of IL-1α, TNFα and their specific inhibitors in undialyzed chronic renal failure, CAPD and hemodialysis patients
Kidney Int
(1994) - et al.
Soluble interleukin-2 receptor molecules in the serum of patients with autoimmune diseases
Clin Immunol Immunopathol
(1989) - et al.
Correlation of plasma interleukin-1 levels with disease activity in rheumatoid arthritis
Lancet
(1988) - et al.
Suppression of chronic myelogenous leukemia colony growth by interleukin-1 (IL-1) receptor antagonist and soluble IL-1 receptors: a novel application for inhibitors of IL-1 activity
Blood
(1991)
Immunological markers of atherosclerosis
Lancet
(1993)
Association of serum antibodies to heat-shock protein 65 with carotid atherosclerosis
Lancet
(1993)
Serum levels of interleukin-6 and acute phase responses
Lancet
(1987)
The immune system and hypertension
Hypertension
(1992)
Serum concentrations of immunoglobulins and free light chains before and after vascular events in essential hypertension
Acta Med Scand
(1983)
Association between disturbances in the immune system and hypertension
Am J Hypertens
(1991)
Thymectomy delays the development of hypertension in Okamoto spontaneously hypertensive rats
J Hypertens
(1987)
Autoantibodies in untreated and treated essential hypertension
Acta Med Scand
(1978)
Association between the C3-F gene and essential hypertension
Clin Sci
(1981)
HLA antigens in borderline and essential hypertension
Am J Hypertens
(1993)
Essential hypertension and histocompatibility antigens: an association study
Hypertension
(1992)
Association of salt sensitivity in rats with genes of the major histocompatibility complex
Hypertension
(1994)
Effect of converting enzyme inhibitor captorpril on T cell functions in essential hypertension
Nephron
(1991)
Captopril enhances in vitro human lymphocyte thymidine incorporation
Agents Action
(1984)
Captopril (SQ14225): in vitro and in vivo influence on the proliferative response of rat lymphocytes
Experimentia
(1982)
The role of IL-1 in disease
N Engl J Med
(1993)
Interleukin-1: a mitogen for human vascular smooth muscle cells that induces the release of growth-inhibitory prostanoids
J Clin Invest
(1988)
Cited by (124)
Circulating cytokines and risk of developing hypertension: A systematic review and meta-analysis
2024, Pharmacological ResearchMechanisms underlying the effects of caloric restriction on hypertension
2022, Biochemical PharmacologyCitation Excerpt :Moreover, in non-hypertensive individuals, elevated CRP levels are associated with increased risk of hypertension [94-96]. Similarly, hypertensive patients exhibit significantly higher plasma levels of IL-6 [97-99], IL1-β [100,101], and TNFα [97,102,103] than non-hypertensive individuals. These inflammatory mediators can downregulate eNOS expression by different mechanisms.
Comorbidities associated with cervical spine degenerative disc disease
2021, Journal of OrthopaedicsThe role of inflammation in hypertension: novel concepts
2021, Current Opinion in PhysiologyThe Role of Pro-Inflammatory Cytokines in the Pathogenesis of Cardiovascular Disease
2024, International Journal of Molecular Sciences
- ☆
Presented at the Sixteenth Scientific Meeting of The International Society of Hypertension, Glasgow, United Kingdom, June 23–27, 1996.
Copyright © 1997 Published by Mosby, Inc.